Head & Face Medicine (Aug 2023)
Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study
Abstract
No abstracts available.
Head & Face Medicine (Aug 2023)